特色文章
Patients With Challenging Cancers to Benefit from Genomic Sequencing
University of Melbourne and Illumina Target Diagnosis of Difficult Cancers
Next-Generation Sequencing Helps Fight Infectious Diseases Globally
Case in Point: The Novel Coronavirus
Illumina因美纳将捐款200万现金，发放免费试剂抗击疫情
面对疫情，因美纳在行动！
一次封城时期的新冠毒株测序纪实
Illumina为这次处于疫病风暴中心的交锋贡献一份正能量。
新闻发布
In the News
| 日期 | 发表 | 标题 |
|---|---|---|
| 2019-10-9 | Yahoo! Finance | Illumina Inks Deal to Commercialize NGS-Based IVD Kits |
| 2019-9-30 | ClinicalOMICs | Illumina and the Broad Co-Developing Open-Source Secondary Analysis Software |
| 2019-2-27 | Bloomberg | A $100 Genome Within Reach, Illumina CEO Asks If World Is Ready |
| 2019-2-27 | Slate | Why Are We So Afraid of Each New Advance in Reproductive Technology? |
| 2019-2-19 | San Diego Union Tribune | San Diego biotech company teams up with doctors to offer genome sequencing to Tijuana children |
更多资源
Investor Information
Careers at Illumina
At Illumina, we push boundaries. We think beyond the conventional. We dream big. With the energy of so many bright and accomplished people, the opportunities are endless.
Search for JobsPress Contacts
If you are a member of the media:
- Email pr@illumina.com
- Tel. 858.882.6822
If you are not a member of the media, please visit Contact Us.